Arintra Raises $21M Series A Led by Peak XV Partners

Gunderson Dettmer represented client Arintra, the leading GenAI-native autonomous medical coding platform for healthcare providers, in its $21 million Series A financing led by Peak XV Partners and with participation from Endeavor Health Ventures, Y Combinator, Counterpart Ventures, Spider Capital and Ten13.

Arintra enables health systems to get paid accurately and efficiently for the care they deliver, driving revenue assurance at scale. By combining cutting-edge AI with deep clinical expertise, Arintra autonomously codes charts with high accuracy, without human intervention. 

Health systems use Arintra to unlock missed revenue due to coding gaps, documentation issues and unchallenged denials—achieving 5%+ uplift in revenue, 12%+ reduction in A/R days and 43%+ fewer denials. Arintra's reimagined approach to medical coding has already processed over a billion dollars in healthcare charges. It has helped customers recover millions of dollars in otherwise missed revenue, while reducing manual work and accelerating cash flow.

The company will use the new capital to expand adoption across health systems and physician groups nationwide, accelerate product development, scale its team and open a new Bay Area headquarters to meet rising demand.

In the announcement of the transaction, Arintra co-founder and CEO Nitesh Shroff said, “Reimbursement in healthcare is fundamentally broken. Payers are moving fast, using policy and technology to shift more burden onto providers, but autonomous coding hasn't kept up. We built Arintra to help healthcare providers secure compliant revenue at scale while easing the burden on frontline teams.”

The Gunderson deal team was led by Brad Krack and included Adam Spaulding and Kevin Mann.

Companies
Arintra
Peak XV Partners
Endeavor Health Ventures
Y Combinator
Counterpart Ventures
Spider Capital
Ten13